Novavax's (NVAX) updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- ...
(RTTNews) - Novavax (NVAX) has filed for authorization with Health Canada for 2024-2025 Formula COVID-19 vaccine or NVX-CoV2705 for individuals aged 12 and older. Novavax plans to have its vaccine ...
GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M ™ adjuvant, today announced that Health Canada has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results